Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Chelation therapy in cardiovascular disease: an update.

Sultan S, Murarka S, Jahangir A, Mookadam F, Tajik AJ, Jahangir A.

Expert Rev Clin Pharmacol. 2017 Aug;10(8):843-854. doi: 10.1080/17512433.2017.1339601. Epub 2017 Jun 19. Review.

PMID:
28597699
2.

Comparison of cardiac stem cell sheets detached by Versene solution and from thermoresponsive dishes reveals similar properties of constructs.

Dergilev KV, Makarevich PI, Tsokolaeva ZI, Boldyreva MA, Beloglazova IB, Zubkova ES, Menshikov MY, Parfyonova YV.

Tissue Cell. 2017 Feb;49(1):64-71. doi: 10.1016/j.tice.2016.12.001. Epub 2016 Dec 16.

PMID:
28041835
3.

Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy.

Lamas GA, Navas-Acien A, Mark DB, Lee KL.

J Am Coll Cardiol. 2016 May 24;67(20):2411-8. doi: 10.1016/j.jacc.2016.02.066. Review.

4.

Chelation therapy in the treatment of cardiovascular diseases.

Ibad A, Khalid R, Thompson PD.

J Clin Lipidol. 2016 Jan-Feb;10(1):58-62. doi: 10.1016/j.jacl.2015.09.005. Epub 2015 Sep 25. Review.

PMID:
26892121
5.

Edetate Disodium-Based Treatment for Secondary Prevention in Post-Myocardial Infarction Patients.

Lamas GA, Issa OM.

Curr Cardiol Rep. 2016 Feb;18(2):20. doi: 10.1007/s11886-015-0690-9. Review.

PMID:
26797807
6.

EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.

Ouyang P, Gottlieb SH, Culotta VL, Navas-Acien A.

Curr Cardiol Rep. 2015 Nov;17(11):96. doi: 10.1007/s11886-015-0656-y. Review.

PMID:
26364188
7.

Cardiology Patient Page. Chelation therapy: a new look at an old treatment for heart disease, particularly in diabetics.

Lamas GA.

Circulation. 2015 May 26;131(21):e505-6. doi: 10.1161/CIRCULATIONAHA.114.010774. No abstract available.

8.

Chelation therapy after the trial to assess chelation therapy: results of a unique trial.

Avila MD, Escolar E, Lamas GA.

Curr Opin Cardiol. 2014 Sep;29(5):481-8. doi: 10.1097/HCO.0000000000000096. Review.

9.

Quality-of-life outcomes with a disodium EDTA chelation regimen for coronary disease: results from the trial to assess chelation therapy randomized trial.

Mark DB, Anstrom KJ, Clapp-Channing NE, Knight JD, Boineau R, Goertz C, Rozema TC, Liu DM, Nahin RL, Rosenberg Y, Drisko J, Lee KL, Lamas GA; TACT Investigators.

Circ Cardiovasc Qual Outcomes. 2014 Jul;7(4):508-16.

10.

EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy.

Lamas GA, Boineau R, Goertz C, Mark DB, Rosenberg Y, Stylianou M, Rozema T, Nahin RL, Terry Chappell L, Lindblad L, Lewis EF, Drisko J, Lee KL.

Am Heart J. 2014 Jul;168(1):37-44.e5. doi: 10.1016/j.ahj.2014.02.012. Epub 2014 Apr 2.

11.

Are concerns about reliability in the trial to assess chelation therapy fair grounds for a hasty dismissal?: An alternative perspective.

Kaul S.

Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):5-7. doi: 10.1161/CIRCOUTCOMES.113.000714. Epub 2014 Jan 14. No abstract available.

12.

The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT).

Escolar E, Lamas GA, Mark DB, Boineau R, Goertz C, Rosenberg Y, Nahin RL, Ouyang P, Rozema T, Magaziner A, Nahas R, Lewis EF, Lindblad L, Lee KL.

Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):15-24. doi: 10.1161/CIRCOUTCOMES.113.000663. Epub 2013 Nov 19.

13.

Chelation therapy and cardiovascular outcomes--in reply.

Lamas GA, Mark D, Lee KL.

JAMA. 2013 Jul 24;310(4):431-2. doi: 10.1001/jama.2013.7954. No abstract available.

PMID:
23917300
14.

Chelation therapy and cardiovascular outcomes.

Kleinman B.

JAMA. 2013 Jul 24;310(4):431. doi: 10.1001/jama.2013.7930. No abstract available.

PMID:
23917299
15.

Chelation therapy and cardiovascular outcomes.

Bittl JA.

JAMA. 2013 Jul 24;310(4):430-1. doi: 10.1001/jama.2013.7933. No abstract available.

PMID:
23917297
16.

From the National Heart, Lung, and Blood Institute (NHLBI): EDTA chelation therapy modestly reduces cardiovascular events.

National Heart, Lung, and Blood Institute.

Ethn Dis. 2013 Summer;23(3):388. No abstract available.

PMID:
23914432
17.

Chelation therapy may improve cardiovascular health.

[No authors listed]

BMJ. 2013 Apr 3;346:f2071. doi: 10.1136/bmj.f2071. No abstract available.

PMID:
23553884
18.

Concerns about reliability in the Trial to Assess Chelation Therapy (TACT).

Nissen SE.

JAMA. 2013 Mar 27;309(12):1293-4. doi: 10.1001/jama.2013.2778. No abstract available.

PMID:
23532246
19.

Evaluation of the Trial to Assess Chelation Therapy (TACT): the scientific process, peer review, and editorial scrutiny.

Bauchner H, Fontanarosa PB, Golub RM.

JAMA. 2013 Mar 27;309(12):1291-2. doi: 10.1001/jama.2013.2761. No abstract available.

PMID:
23532245
20.

Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial.

Lamas GA, Goertz C, Boineau R, Mark DB, Rozema T, Nahin RL, Lindblad L, Lewis EF, Drisko J, Lee KL; TACT Investigators.

JAMA. 2013 Mar 27;309(12):1241-50. doi: 10.1001/jama.2013.2107.

Supplemental Content

Loading ...
Support Center